Evidence map›Paper›PMID 30976179›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2019

Dose-response evaluation of a copaiba-containing varnish against streptococcus mutans in vivo.

Lídia Audrey Rocha Valadas, Mariana Fernandes Gurgel, Joelma Martins Mororó, Said Gonçalves da Cruz Fonseca, Cristiane Sá Roriz Fonteles, Cibele Barreto Mano de Carvalho, Francisco Vagnaldo Fechine, Edilson Martins Rodrigues Neto, Marta Maria de França Fonteles, Francineudo Oliveira Chagas and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05308732 (Phase I Study of Multiple Ascending Dose, to Investigate the Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05308732 phase1active not recruitingnot on this mapstarted 2021, after this paper: background citation

Phase I Study of Multiple Ascending Dose, to Investigate the Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

TypeinterventionalSponsorInstituto Nacional de Cancer, BrazilRan2021 to 2026Enrolled20ConditionsHead and Neck Neoplasms, Mucositis Oral, Radiotherapy, ComplicationsArmsCopaiba
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Efficacy ofInternational journal of dentistry · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Clinical and Antimicrobial Evaluation ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  8. Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lídia Audrey Rocha ValadasPostgraduate Program in Drug Development, School of Pharmacy, Federal University of Ceará, Brazil.
Mariana Fernandes GurgelDepartment of Clinical Dentistry, School of Dentistry-Campus Sobral, Federal University of Ceará, Brazil.
Joelma Martins MororóDepartment of Clinical Dentistry, School of Dentistry-Campus Sobral, Federal University of Ceará, Brazil.
Said Gonçalves da Cruz FonsecaPostgraduate Program in Drug Development, School of Pharmacy, Federal University of Ceará, Brazil.
Cristiane Sá Roriz FontelesPostgraduate Program in Dentistry, Department of Clinical Dentistry, School of Dentistry, Federal University of Ceará, Brazil.
Cibele Barreto Mano de CarvalhoDepartment of Pathology and Legal Medicine, School of Medicine, Federal University of Ceará, Brazil.
Francisco Vagnaldo FechineClinical Pharmacology Unit, Department of Pharmacology, School of Medicine, Federal University of Ceará, Brazil.
Edilson Martins Rodrigues NetoPostgraduate Program in Drug Development, School of Pharmacy, Federal University of Ceará, Brazil.
Marta Maria de França FontelesPostgraduate Program in Drug Development, School of Pharmacy, Federal University of Ceará, Brazil.
Francineudo Oliveira ChagasDepartment of Clinical Dentistry, School of Dentistry-Campus Sobral, Federal University of Ceará, Brazil.
Patrícia Leal Dantas LoboPostgraduate Program in Drug Development, School of Pharmacy, Federal University of Ceará, Brazil.
Mary Anne Medeiros BandeiraPostgraduate Program in Drug Development, School of Pharmacy, Federal University of Ceará, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDental caries is the most prevalent disease in humans and its incidence is particularly high during childhood. The use of medicinal plants is a common practice in Brazil.

objectiveTo evaluate the optimal antimicrobial concentration of

methodsTwenty-four children, caries-free, aged until 6 years old, were selected to participate in this study. The varnish was applied to the occlusal surfaces of all deciduous molars. The antimicrobial activity was analyzed in saliva, whose collection was conducted in two phases: before applying the copaiba varnish and after use to verify the instantaneous effectiveness of

resultsComparisons between different times within the same dilution were carried out by repeated measures analysis of variance (ANOVA) associated with Tukey's multiple comparisons test. Comparisons of conditions prior to and after treatment were performed using the

conclusionCopaiba oil-resin, in the form of dental varnish, has antimicrobial activity against

Indexed as

Dental cariesSalivaStreptococcus mutans

Identifiers

PMID30976179
PMCPMC6438705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.